Tocilizumab significantly reduced 28-day mortality and length of ICU stay in patients with severe COVID-19 pneumonia and low S-spike nAb titers.

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

Market OverviewThe global Epilepsy Drugs Market is valued at USD 10.63 billion in 2024 and is projected to reach a value ...

Does colchicine work for CVD or doesn’t it? That’s the question the study authors hoped to answer, but there’s little ...

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we ...

A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

The global lipid nanoparticles (LNP) contract development and manufacturing organization (CDMO) market is poised for substantial double-digit growth by 2027, driven by the growing acceptance of LNPs ...

Global Consumer Healthcare market is valued at approximately USD 539.59 billion in 2023 and is anticipated to expand at a robust CAGR of 6.78% over the forecast period from 2024 to 2032. Request To ...

"Tiger King" star Bhagavan "Doc" Antle was sentenced Tuesday to one year and a day in federal prison and fined $55,000 for ...

Health ministry has issued statement highlighting that extensive studies by ICMR and AIIMS, New Delhi have established there ...

During the 2019 pandemic sweeping through hospitals, an insidious companion emerged in bloodstream infections, where bacteria ...